(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ELIXADA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ELIXADA

ST13

US500000088902639

Class

5

Filing

88902639

Registration

6406637

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

21

Latest update

07/06/2026

Trademark type

Word

Nice classes

5

Filing date

05/06/2020

Registration date

07/06/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/06/2021

Last transaction

07/06/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

16

Owner location

King of Prussia, PA, US

Examiner

JOHNSON, CLINTON J

Law office

L70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

CSL Behring L.L.C.

Representatives

Scott D. Woldow SMITH, GAMBRELL & RUSSELL, LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment and prevention of blood and bleeding disorders; blood products for the treatment of hemophiliapharmaceutical preparations for the treatment of hemophilia; pharmaceutical products derived from recombinant DNA technology for the treatment of hemophiliapharmaceutical preparations derived from recombinant DNA technology for the treatment of hemophilia; blood products for the treatment of hemophilia in the nature of pharmaceutical preparationsa blood clotting aid and delivery system for use in human and veterinary medicine; pharmaceutical preparations and substances for the treatment of blood disorders

Publications

History of USPTO decisions and trademark events.

21 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

07/06/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

07/06/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/20/2021

PUBO

PUBLISHED FOR OPPOSITION

04/20/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/31/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/17/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/15/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/15/2021

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

03/15/2021

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

03/01/2021

GNFR

FINAL REFUSAL E-MAILED

03/01/2021

CNFR

FINAL REFUSAL WRITTEN

03/01/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/27/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/27/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/27/2021

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/08/2020

GNRT

NON-FINAL ACTION E-MAILED

08/08/2020

CNRT

NON-FINAL ACTION WRITTEN

08/08/2020

DOCK

ASSIGNED TO EXAMINER

08/01/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/18/2020

NWAP

NEW APPLICATION ENTERED

05/09/2020

Continuous trademark protection

Get notified about every new filing that threatens ELIXADA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.